美国Covidien
Covidien(柯惠)的前身是泰科医疗(Tyco Healthcare)。
Covidien Ltd（纽约证券交易所：COV、百慕大证券交易所：COV）是全球领先的卫生保健产品公司，其创建革新的医疗解决方案，通过临床领导能力及卓越的表现来使病人实现更好的结果，并实现价值。Covidien制造、分销多种业界领先的产品线，并为这些产品线提供服务，包括外科设备、基于能量的设备、呼吸和监控解决方案、病人护理与安全产品、影像解决方案、医药产品、医疗用品。2006年，Covidien的收入达到近100亿美元，在世界上的57个国家中雇有43,000名员工，其产品销往130多个国家。2007年7月2号开始在纽约证券交易所和百慕大证券交易所进行交易，这意味着公司首次成为独立的多元化医疗保健产品公司。这也表示众所周知的Tyco Healthcare业务最近从Tyco International中正独立。

　　凭借业界领先的品牌名称（包括：Autosuture、Kendall、Mallinckrodt、Nellcor、Puritan Bennett、Syneture、U.S.Surgical和Valleylab），Covidien在医疗设备、影像解决方案、医药产品、医疗用品以及零售产品产品等五大业务部门在市场上竞争。2006年，Covidien收益达到96亿美元，其中三分之一以上的销售额是在美国以外实现的。 Covidien在57个国家雇有43,000名员工，其产品销往130多个国家。

Covidien五大业务部门的特色
　　医疗设备部（占销售的59％）

医疗设备部是最大的业务部门，在2006年其净销售额达到了57亿美元。
这一多样化产品部门在多种医疗设备市场是全球领先者，其单一产品的销售额不超过总销售额的1％。
体现了Covidien在全球广泛的足迹，医疗设备销售中有54％是在美国以外实现的。
对于外科设备、能量设备、呼吸和监控解决方案、病人护理和安全产品以及众多革新产品来说，医疗设备部是最重要的部门。
　　影像解决方案部（占销售的9％）　　

在2006年，影像解决方案产品的净销售额达90亿美元。
Covidien影像解决方案部以最精确的早期疾病诊断为终极目标，在生产多种形态的放射性药剂（X-ray、MRI和核医疗）、造影剂和造影交付系统方面是全球领先者。
遵循全企业创新哲学，影像解决方案部将医疗影像技术从注重‘解剖和功能影像技术转移到‘分子级影像技术’上。这种转变可帮助临床医生在更早的阶段进行疾病诊断、治疗和监控。
　　医药产品部（占销售额的13％）

2006年实现的净销售额达到12亿美元，拥有多个产品线，从配药医药品到药物活性成分以及特制化学产品。
Covidien是美国第九大医药公司（拥有众多配药处方）
作为世界上控制中枢神经类物质的最大制造商，Covidien是病人安全与及控制中枢神经类物质调节方面的先驱。
Covidien也是醋氨酚以及其它多种止痛药品的全球领先者
　　医疗用品部（占销售额的10％）

在2006年净销售额达近10亿美元，医疗用品部是病人护理材料领域的领先者。
Covidien的各种产品让手术室、护理站和医师的办公室中拥有最高质量的临床材料。
产品线包括：伤口护理材料、医疗外科产品、原始设备制造商产品、失禁用品（欧洲）以及其它产品。
在核心医疗用品类中，Covidien的市场份额位居第一或第二。
　　零售产品部（占销售额的9％）

在零售产品部门，Covidien是北美地区自有品牌成人失禁产品、婴儿护理产品以及女性卫生产品领域的领先制造商，在2006年的净销售额达到8亿美元。
在美国20家顶级零售商中，Covidien是为17家提供自有品牌成人失禁产品、婴儿护理产品以及女性卫生产品的独家或者多家授权供货商。

At Covidien, we're passionate about making doctors, nurses, pharmacists and other medical professionals as effective as they can be. From Autosuture to Valleylab, from Kendall to Mallinckrodt, our industry-leading brands are known worldwide for uncompromising quality.

Through ongoing collaboration with medical professionals and organizations, we identify clinical needs and translate them into proven products and procedures. Over the years, we've pioneered a number of medical advances including contrast media, pulse oximetry, electrosurgery, surgical stapling and laparoscopic instrumentation.

Offering an extensive product line that spans medical devices, imaging solutions, pharmaceuticals and medical supplies, we serve healthcare needs in hospitals, long-term care and alternate care facilities, doctors’ offices and in the home.

International in every respect Covidien is part of the local fabric of the communities where we operate. Deriving 45% of our sales from outside the United States, Covidien's success wouldn’t be possible without the dedication of our 41,000 employees, who live in 59 countries. More than two-thirds of our colleagues work in 60 manufacturing facilities, located in 16 countries. In addition, more than 4,800 sales representatives in more than 50 countries meet our customers’ needs every day.

Strategic Initiatives, Core strengths At Covidien, we believe that supporting the lifesaving work of medical professionals and emphasizing growth are not mutually exclusive. In fact, our financial stability enables us to hold to our vision of being an essential resource to the healthcare profession and therefore to doing our part to improve patient outcomes.

With that in mind, we have outlined the following strategic initiatives:

Focus on Growth
Commitment to Innovation
Leveraging Our Global Structure
Driving Operational Excellence
Increased Portfolio Management
We're confident that we will succeed in these areas because of our core strengths:

Scale, product diversity and reach. As one of the largest global manufacturers and marketers in the healthcare industry, our scale and diversity allow us to invest wisely in infrastructure and technology and to develop lower cost sources of supply and global distribution. We offer products in a number of high growth healthcare areas, including laparoscopic surgery, electrosurgery, biosurgery, sleep therapy and pain management.
A portfolio of leading brands. Our brands are among the most well-known and respected in the healthcare field. Quality and reliability are their hallmarks.
Strong customer relationships. Our sales force develops and maintains strong relationships with clinician decision makers. We foster these relationships by providing extensive clinical education through dedicated training centers, by sponsoring fellowships and offering other continuing education programs.
Operational excellence. We have a history of developing and manufacturing high-quality products in a cost-effective manner. Throughout our organization, we are committed to Six Sigma, Design for Six Sigma, Lean Manufacturing and strategic sourcing initiatives to ensure product availability. We employ strict safety and quality controls to reduce disruption throughout the supply chain.
Our aim is to enhance growth by increasing research and development initiatives, pursuing targeted acquisition opportunities and enhancing our global infrastructure, including sales, marketing and distribution.